UBS AM’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250,855
| Closed | -$554K | – | 2687 |
|
|
2025
Q1 | $554K | Sell |
250,855
-359
| -0.1% | -$793 | ﹤0.01% | 2481 |
|
|
2024
Q4 | $1.37M | Buy |
251,214
+45,454
| +22% | +$248K | ﹤0.01% | 2223 |
|
|
2024
Q3 | $1.71M | Sell |
205,760
-28,587
| -12% | -$238K | ﹤0.01% | 2127 |
|
|
2024
Q2 | $1.68M | Buy |
234,347
+37,284
| +19% | +$267K | ﹤0.01% | 2093 |
|
|
2024
Q1 | $1.71M | Hold |
197,063
| – | – | ﹤0.01% | 1767 |
|
|
2023
Q4 | $1.29M | Sell |
197,063
-433,332
| -69% | -$2.84M | ﹤0.01% | 1894 |
|
|
2023
Q3 | $6.3M | Sell |
630,395
-752,375
| -54% | -$7.52M | ﹤0.01% | 1124 |
|
|
2023
Q2 | $19.4M | Hold |
1,382,770
| – | – | 0.01% | 777 |
|
|
2023
Q1 | $19.4M | Buy |
+1,382,770
| New | +$19.4M | 0.01% | 777 |
|
|
2022
Q4 | – | Sell |
-2,152,901
| Closed | -$55M | – | 2686 |
|
|
2022
Q3 | $55M | Sell |
2,152,901
-312,997
| -13% | -$7.99M | 0.03% | 510 |
|
|
2022
Q2 | $70.1M | Sell |
2,465,898
-269,506
| -10% | -$7.66M | 0.04% | 470 |
|
|
2022
Q1 | $96.5M | Sell |
2,735,404
-1,780,696
| -39% | -$62.8M | 0.04% | 445 |
|
|
2021
Q4 | $189M | Buy |
4,516,100
+382,914
| +9% | +$16M | 0.07% | 287 |
|
|
2021
Q3 | $203M | Buy |
4,133,186
+594,447
| +17% | +$29.2M | 0.08% | 250 |
|
|
2021
Q2 | $148M | Buy |
3,538,739
+248,796
| +8% | +$10.4M | 0.06% | 329 |
|
|
2021
Q1 | $117M | Sell |
3,289,943
-473,069
| -13% | -$16.9M | 0.05% | 384 |
|
|
2020
Q4 | $106M | Buy |
+3,763,012
| New | +$106M | 0.05% | 391 |
|